Gilead Sciences Inc Stock Forecast for 2023 - 2025 - 2030

Updated on 02/28/2024

Stock Rating
11
Price Target
$88.70
Consensus
Outperform
Upside
21.47%
Analysts
14
Stock Rating
11
Upside
21.47%
Analysts
14
Price Target
$88.70

Gilead Sciences Inc Stock Forecast and Price Target

The average price target of $88.70 for Gilead Sciences Inc's stock set by fourteen distinguished analysts in recent weeks would represent a potential upside of approximately 21.47% from the last closing price in February, 2024 if reached by the end of the year. This potential increase is based on a high estimate of $120.00 and a low estimate of $69.00. If you're interested in GILD stock, it's important to compare it to other companies in the industry.

$88.70

21.47% Upside

Outperform
Outperform

Gilead Sciences Inc Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Gilead Sciences Inc's Price has seen a drop from $77.00 to $0.00 – a 100.00% decrease. For the next year, analysts predict that Fair Value will reach $75.80 – an increase of 100.00%. Over the next seven years, experts believe that Gilead Sciences Inc's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
$75.80
2025 Fair Value Forecast
$78.52
2026 Fair Value Forecast
$76.24
2027 Fair Value Forecast
$80.80
2028 Fair Value Forecast
$85.25
2029 Fair Value Forecast
$85.90
2030 Fair Value Forecast
$86.66
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ABBV Stock Forecast AbbVie Outperform 9
$178.99 Buy/Sell $178.42 0.56%
AMGN Stock Forecast Amgen Outperform 4
$278.49 Buy/Sell $303.65 13.11%
ALXN Stock Forecast Alexion Pharmaceuticals - 0
$182.50 Buy/Sell $177.38 -100.00%
BIIB Stock Forecast Biogen Outperform 10
$223.94 Buy/Sell $299.62 32.62%
BMRN Stock Forecast BioMarin Pharmaceutical Outperform 10
$90.68 Buy/Sell $111.56 20.73%

Gilead Sciences Inc Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Gilead Sciences Inc's Revenue has grown by 9.83%, rising from $24.69B to $27.12B. According to 20 major analysts, Gilead Sciences Inc's Revenue will fall by 5.96% in the next year, reaching $25.50B. Professionals believe that By 2030, Gilead Sciences Inc's Revenue will fall to $26.09B– a 3.79% decrease from its current value.

2024 Rev Forecast
$25.50B
2025 Rev Forecast
$25.84B
2026 Rev Forecast
$25.43B
2027 Rev Forecast
$25.75B
2028 Rev Forecast
$26.15B
2029 Rev Forecast
$25.97B
2030 Rev Forecast
$26.09B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
INCY Stock Forecast Incyte Outperform 9
$61.00 Buy/Sell $77.05 26.56%
EXEL Stock Forecast Exelixis Outperform 16
$21.71 Buy/Sell $26.44 24.37%
ARNA Stock Forecast Arena Pharmaceuticals - 6
$99.99 Buy/Sell $100.00 -100.00%

Gilead Sciences Inc Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, Gilead Sciences Inc's Dividend per Share has grown, moving from $2.72 to $3.00 – an increase of 10.29%. In the next year, analysts predict that Dividend per Share will jump to $3.35 – up 11.67% from the current level. Looking ahead to seven years, experts forecast that Dividend per Share will grow by 111.67%.

2024 DPS Forecast
$3.35
2025 DPS Forecast
$3.62
2026 DPS Forecast
$3.72
2027 DPS Forecast
$4.77
2028 DPS Forecast
$5.25
2029 DPS Forecast
$5.77
2030 DPS Forecast
$6.35
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BPMC Stock Forecast Blueprint Medicines Outperform 6
$99.79 Buy/Sell $85.71 0.21%
IOVA Stock Forecast Iovance Biotherapeutics Buy 4
$17.47 Buy/Sell $20.42 40.24%
FOLD Stock Forecast Amicus Therapeutics Outperform 7
$13.85 Buy/Sell $17.90 44.40%

Gilead Sciences Inc Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$8.99B
2025 FCF Forecast
$10.39B
2026 FCF Forecast
$10.27B
2027 FCF Forecast
$10.22B
2028 FCF Forecast
$10.45B
2029 FCF Forecast
$10.43B
2030 FCF Forecast
$10.42B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ACAD Stock Forecast ACADIA Pharmaceuticals Outperform 6
$26.36 Buy/Sell $33.78 32.78%
CCXI Stock Forecast ChemoCentryx - 8
$51.99 Buy/Sell $52.00 -100.00%
CBAY Stock Forecast CymaBay Therapeutics Hold 8
$32.32 Buy/Sell $27.73 0.56%

Gilead Sciences Inc EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Gilead Sciences Inc's EBITDA has decreased from $12.70B to $12.57B – a 1.03% drop. In the next year, analysts believe that EBITDA will reach $12.66B – an increase of 0.78%. For the next seven years, the forecast is forEBITDA to grow by 32.37%.

2024 EBITDA Forecast
$12.66B
2025 EBITDA Forecast
$13.98B
2026 EBITDA Forecast
$13.98B
2027 EBITDA Forecast
$16.28B
2028 EBITDA Forecast
$15.80B
2029 EBITDA Forecast
$16.14B
2030 EBITDA Forecast
$16.63B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ARWR Stock Forecast Arrowhead Pharmaceuticals Outperform 7
$31.17 Buy/Sell $52.00 76.45%
VKTX Stock Forecast Viking Therapeutics Buy 5
$85.05 Buy/Sell $34.00 -50.62%
DRNA Stock Forecast Dicerna Pharmaceuticals - 7
$38.01 Buy/Sell $35.06 -100.00%

Gilead Sciences Inc EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Gilead Sciences Inc's EBIT has decreased by 11.80%, going from $11.22B to $9.89B. In the coming year, analysts are expecting an increase in EBIT, predicting it will reach $11.55B – an increase of 16.78%. Over the next seven years, experts anticipate that EBIT growth for Gilead Sciences Inc will be 27.55%.

2024 EBIT Forecast
$11.55B
2025 EBIT Forecast
$11.65B
2026 EBIT Forecast
$11.17B
2027 EBIT Forecast
$12.00B
2028 EBIT Forecast
$12.55B
2029 EBIT Forecast
$12.55B
2030 EBIT Forecast
$12.62B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
VCEL Stock Forecast Vericel Buy 8
$48.00 Buy/Sell $42.58 -5.21%
ARDX Stock Forecast Ardelyx Buy 11
$9.67 Buy/Sell $9.94 37.02%
CLDX Stock Forecast Celldex Therapeutics Buy 11
$51.04 Buy/Sell $63.29 43.03%

Gilead Sciences Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Gilead Sciences Inc's EPS has seen a drop from $7.09 to $0.00 – a 100.00% decrease. For the next year, analysts predict that EPS will reach $6.98 – an increase of 100.00%. Over the next seven years, experts believe that Gilead Sciences Inc's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
$6.98
2025 EPS Forecast
$7.23
2026 EPS Forecast
$7.02
2027 EPS Forecast
$7.44
2028 EPS Forecast
$7.85
2029 EPS Forecast
$7.91
2030 EPS Forecast
$7.98
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
AGIO Stock Forecast Agios Pharmaceuticals Outperform 9
$34.81 Buy/Sell $40.00 24.96%
DVAX Stock Forecast Dynavax Technologies Outperform 11
$12.99 Buy/Sell $25.00 88.61%
XNCR Stock Forecast Xencor Outperform 6
$26.52 Buy/Sell $37.91 35.75%